STAR: Strides Pharma Science Limited has informed the Exchange about Intimation regarding Communication to Shareholders on TDS for Final Dividend for FY 2024 25
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science has informed the exchange about a communication sent to shareholders regarding Tax Deducted at Source (TDS) on the final dividend for FY 2024-25. The Board had recommended a final dividend of Rs. 4 per equity share (face value Rs. 10) on May 22, 2025, subject to shareholder approval at the AGM on August 7, 2025. The record date for determining dividend entitlement is Tuesday, July 22, 2025. The communication details TDS rates for different shareholder categories (10% for resident PAN holders, 20% without PAN, and DTAA options for non-residents) and the documents shareholders need to submit to claim exemptions or lower rates by July 22, 2025.
This is a procedural tax-deduction communication related to the already-announced Rs. 4 final dividend, not a new corporate action. Shareholders should ensure their PAN, bank, and contact details are updated with the RTA or depository before July 22, 2025, to avoid higher TDS deduction (20% instead of 10%). No direct impact on stock price is expected from this filing.